Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY

Journal of Thoracic Oncology 2026 Open access

Read full text

Authors: Pawan Kumar Singh

DOI: 10.1016/j.jtho.2026.103577

Cited by: 1

References: 10

Fields of Study & Subjects

HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies

References 10